Clinical Trial

Treatment With Indapamide in Patients With Post-Surgical Hypoparathyroidism

Study acronym: HYPOCARE treat
Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated August 11, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of this study is to investigate the effect of daily treatment with Indapamide for 14 days on urinary calcium excretion in patients with post surgical hypoparathyroidisme.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-15.
Trial Details
NCT Number NCT07034677
Lead Sponsor Lars Rejnmark
Conditions Hypoparathyroidism Post-surgical
Enrollment 24 participants
Start Date 2025-08
Primary Completion 2025-12 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-08-11